UVA Discovers Key Driver of High Blood Pressure – UVA Health Newsroom

The discovery from UVAs Swapnil Sonkusare, PhD, and colleagues breaks new ground in our understanding of how the body regulates blood pressure.

School of Medicine researchers have identified a key contributor to high blood pressure that could lead to new treatments for a condition which affects almost half of American adults.

The discovery from UVAs Swapnil Sonkusare, PhD, and colleagues breaks new ground in our understanding of how the body regulates blood pressure. It also shows how problems with this critical biological process drive high blood pressure, also known as hypertension.

UVAs research, published in the scientific journal Circulation, identifies a new paradigm in hypertension, according to an accompanying editorial. The editorial says UVAs innovative discoveries fill major gaps in our understanding of the fundamental molecular causes of high blood pressure.

Our work identifies a new mechanism that helps maintain healthy blood pressure and shows how abnormalities in this mechanism can lead to hypertension, said Sonkusare, of UVAs Department of Molecular Physiology and Biological Physics and UVAs Robert M. Berne Cardiovascular Research Center. The discovery of a new mechanism for elevation of blood pressure could provide therapeutic targets for treating hypertension.

High blood pressure is estimated to affect more than 116 million American adults. In 2020, it contributed to or caused more than 670,000 deaths in the United States, the federal Centers for Disease Control and Prevention reports. Left unchecked, the condition can damage the heart and increase the risk for stroke and other health problems.

Our blood pressure is controlled, in part, by calcium levels in smooth muscle cells that line blood vessel walls. Smooth muscle cells transport calcium in and use it to regulate the contraction of blood vessels as needed. High blood pressure is commonly treated with calcium blockers that reduce the movement of calcium, but these medications have many side effects because they block a mechanism that is used by multiple organs in the body for carrying out normal functions. So a treatment option that targets the harmful effects of calcium but not its beneficial effects could be very helpful for patients with hypertension.

Sonkusare and his team discovered two critical and previously unknown -- signaling centers in smooth muscle cells that bring in calcium and regulate blood pressure. These nanodomains, the researchers found, act like symphony conductors for blood vessels, directing them to contract or relax as needed. These signaling centers, the researchers determined, are a key regulator of healthy blood pressure.

Further, the UVA scientists found that disruptions in this process contribute to high blood pressure. In both mouse models of the disease and hypertensive patients, the fine balance between constrictor and dilator signaling centers is lost. This caused the blood vessels to become too constricted, driving up blood pressure.

The new findings help us better understand how our bodies maintain proper blood pressure and provide enticing targets for scientists seeking to develop treatments targeting underlying causes of hypertension. Developing treatments that do not affect the beneficial effects of calcium will require additional research and a deeper understanding of the calcium-use process, but Sonkusares team is already working toward that goal.

Weve shown that smooth muscle cells use spatial separation of signaling centers to achieve constriction or dilation of arteries. We are now investigating the individual components of these signaling centers, Sonkusare said. Understanding these components will help us target them to lower or raise the blood pressure in disease conditions that show high or low blood pressure, respectively.

The researchers have published their findings in the scientific journal Circulation. The team consisted of Yen-Lin Chen, Zdravka Daneva, Maniselvan Kuppusamy, Matteo Ottolini, Thomas M. Baker, Eliska Klimentova, Soham A. Shah, Jennifer D. Sokolowski, Min S. Park and Sonkusare.

The work was supported by the American Heart Association, grant POST833691; theAmerican Physiological Society; the National Institutes of Health, grants HL146914, HL142808 and HL147555; and the Neurosurgery Research and Education Foundation.

The editorial accompanying the article was written by Rhian Touyz,MD, PhD, of the Research Institute of McGill University Health Centre at Canadas McGill University.

Sonkusare previously discovered why obesity causes high blood pressure.

To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog.

See original here:
UVA Discovers Key Driver of High Blood Pressure - UVA Health Newsroom